Zhu Shuyi, Xu Yanxin, Wang Lin, Chen Jing, Luo Aoxiang
School of Nursing, Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510310, People's Republic of China.
Department of Spinal Orthopedics, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, 510317, People's Republic of China.
J Pain Res. 2025 Aug 6;18:3919-3932. doi: 10.2147/JPR.S526179. eCollection 2025.
Kinesiophobia presents a significant barrier to rehabilitation across multiple conditions. While cognitive behavioral therapy (CBT) holds potential for addressing phobic responses, its specific efficacy against kinesiophobia requires clarification.
To systematically evaluate CBT's efficacy in reducing kinesiophobia among adults.
Following Cochrane guidelines, two independent reviewers searched six international databases (PubMed, Cochrane Library, Embase, EBSCO, Web of Science, Scopus) and four Chinese databases (SinoMed, CNKI, VIP, WanFang) for randomized controlled trials (RCTs) on CBT interventions targeting kinesiophobia, from inception through November 2024. Independent dual review was conducted for study selection, data extraction, and quality assessment (Cochrane Risk of Bias tool). Random-effects meta-analyses were performed using RevMan 5.4 and Stata 12, with heterogeneity quantified by I² statistics.
Eight trials with 938 participants were included. CBT demonstrated significantly greater reduction in kinesiophobia scores versus controls (MD=-5.67, [95% CI:-6.99, -4.35], ). Notably, effects were more pronounced for lumbar conditions (MD=-6.97, 95% CI [-9.97, -3.96], ). Compared with CBT combined with other therapies (MD=-5.23, 95% CI [-7.95, -2.51], ), monotherapy CBT demonstrates greater superiority(MD=-5.96, 95% CI [-7.66,-4.26], ). In terms of follow-up duration, medium and long-term (3 months < follow-up time ≤6 months) (MD=-8.61, 95% CI [-9.72,-7.50], ), 6 months < follow-up time ≤12 months (MD=-11.63, 95% CI [-13.41,-9.84], ) achieves better outcomes in reducing patients' kinesiophobia levels than short-term (follow-up time ≤3 months) (MD=-7.69, 95% CI [-9.47,-5.90], ).
This meta-analysis provides robust evidence that CBT effectively reduces kinesiophobia, particularly as monotherapy for lumbar conditions with sustained follow-up. Clinicians should prioritize CBT implementation to enhance recovery. While results are compelling, confirmatory trials with rigorous methodology and adequate power are warranted.
运动恐惧对多种疾病的康复构成了重大障碍。虽然认知行为疗法(CBT)有潜力解决恐惧反应,但其对运动恐惧的具体疗效仍需阐明。
系统评价CBT在降低成年人运动恐惧方面的疗效。
按照Cochrane指南,两名独立评审员检索了六个国际数据库(PubMed、Cochrane图书馆、Embase、EBSCO、科学引文索引、Scopus)和四个中文数据库(中国生物医学文献数据库、中国知网、维普资讯、万方数据),以查找从创刊至2024年11月期间针对运动恐惧的CBT干预措施的随机对照试验(RCT)。对研究选择、数据提取和质量评估(Cochrane偏倚风险工具)进行独立双审。使用RevMan 5.4和Stata 12进行随机效应荟萃分析,异质性用I²统计量量化。
纳入了八项试验,共938名参与者。与对照组相比,CBT在降低运动恐惧评分方面有显著更大幅度的下降(平均差=-5.67,[95%置信区间:-6.99,-4.35])。值得注意的是,对腰椎疾病的效果更为显著(平均差=-6.97,95%置信区间[-9.97,-3.96])。与CBT联合其他疗法相比(平均差=-5.23,95%置信区间[-7.95,-2.51]),CBT单一疗法显示出更大的优势(平均差=-5.96,95%置信区间[-7.66,-4.26])。在随访持续时间方面,中长期(3个月<随访时间≤6个月)(平均差=-8.61,95%置信区间[-9.72,-7.50])、6个月<随访时间≤12个月(平均差=-11.63,95%置信区间[-13.41,-9.84])在降低患者运动恐惧水平方面比短期(随访时间≤3个月)(平均差=-7.69,95%置信区间[-9.47,-5.90])取得更好的效果。
这项荟萃分析提供了有力证据,表明CBT能有效降低运动恐惧,特别是作为腰椎疾病的单一疗法并进行持续随访。临床医生应优先实施CBT以促进康复。虽然结果令人信服,但仍需要采用严格方法和足够效力的验证性试验。